Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date16 May 1994 |
100 Clinical Results associated with ShinKwang New Drugs Co., Ltd.
0 Patents (Medical) associated with ShinKwang New Drugs Co., Ltd.
100 Deals associated with ShinKwang New Drugs Co., Ltd.
100 Translational Medicine associated with ShinKwang New Drugs Co., Ltd.